Dihydromyricetin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro partially via the activation of Wnt/β-catenin signaling pathway.

Zhang, Wei

Dihydromyricetin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells in vitro partially via the activation of Wnt/β-catenin signaling pathway. [electronic resource] - Fundamental & clinical pharmacology Dec 2016 - 596-606 p. digital

Publication Type: Journal Article

1472-8206

10.1111/fcp.12225 doi


Adaptor Proteins, Signal Transducing
Alkaline Phosphatase--metabolism
Bone Morphogenetic Proteins--metabolism
Bone and Bones--drug effects
Cell Differentiation--drug effects
Cell Proliferation--drug effects
Cells, Cultured
Flavonoids--physiology
Flavonols--pharmacology
Genetic Markers
Humans
Intercellular Signaling Peptides and Proteins--metabolism
Mesenchymal Stem Cells--drug effects
Osteoblasts--drug effects
Osteogenesis--drug effects
Wnt Signaling Pathway--drug effects
beta Catenin--metabolism